2006
DOI: 10.1590/s1678-91992006000300012 View full text |Buy / Rent full text
|
|

Abstract: Snake antivenom, an expensive animal product, is presently the only effective treatment for the consequences of snakebite. In Latin America, antivenoms are mainly produced by public institutions with frequent shortages of the necessary supply. Here, we present an economical analysis of the factors affecting production cost, assuming a basic processing batch of 100 L hyperimmune plasma. Three annual production volumes were considered for two typical production technologies. The components of cost were classifie… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
28
0

Publication Types

Select...

Relationship

0
0

Authors

Journals